3rd Quarter - Report — EDWARDS LIFESCIENCES, LLC for EDWARDS LIFESCIENCES LLC (2026)

Firm

EDWARDS LIFESCIENCES, LLC

Client

EDWARDS LIFESCIENCES LLC

Income

—

Expenses

$300,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Ensuring Patient Access to Critical Breakthrough Products (H.R.5343/S.1717) Regulatory Alignment for Predictable and Immediate Device coverage pathway Policies promoting medical innovation Heart Valve Disease Awareness AI in Healthcare FDA Reauthorization/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development

Lobbyist	Covered position, as disclosed
JENNIFER KUSKOWSKI	—
BRIAN LOOSER	—
MEGHAN O'BRIEN	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 1717 (119th), H.R. 5343 (119th)

Medicare/Medicaid MMM

CMS Coverage Policies For Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.5343/S.1717) (includes RAPID) Heart Valve Disease Awareness National Coverage Determination for TAVR Clinical Trials Coverage with Evidence Development

Lobbyist	Covered position, as disclosed
JENNIFER KUSKOWSKI	—
BRIAN LOOSER	—
MEGHAN O'BRIEN	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5343 (119th), S. 1717 (119th)

Trade (domestic/foreign) TRD

Tariffs

Lobbyist	Covered position, as disclosed
JENNIFER KUSKOWSKI	—
BRIAN LOOSER	—
MEGHAN O'BRIEN	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.